Sandro Vivona

Title: **The Innovative Contributions of Sandro Vivona**

Introduction

Sandro Vivona, an inventive force located in Menlo Park, California, has made significant strides in the field of biotechnology. With a remarkable portfolio of seven patents, he is recognized for his contributions to the development of biologically active molecules, particularly in the realm of single domain antibodies.

Latest Patents

Sandro’s latest innovations include two notable patents:

1. **IL10RA binding molecules and methods of use** - This patent pertains to biologically active molecules that feature a single domain antibody (sdAb) specifically designed to bind to the extracellular domain of human IL10Ra. It encompasses various compositions comprising such antibodies and describes their methods of application.

2. **IL10RB binding molecules and encoding nucleic acids** - This innovative disclosure focuses on biologically active molecules, again utilizing sdAbs, that specifically bind to the extracellular domain of human IL10Rb. It outlines the compositions related to these antibodies and their potential methods of use.

Career Highlights

Sandro is currently associated with Synthekine, Inc., a company known for its cutting-edge research and development in therapeutic proteins. His work at Synthekine has positioned him as a key player in advancing our understanding and application of immune modulation therapies.

Collaborations

Throughout his career, Sandro has collaborated with a talented group of professionals. Notable among his coworkers are Robert Kastelein and Deepti Rokkam, both of whom contribute to the dynamic research environment at Synthekine. Their collaborative efforts foster an innovative atmosphere that is conducive to the development of groundbreaking therapies.

Conclusion

Sandro Vivona is a distinguished inventor whose patents reflect a dedicated pursuit of innovations in the biotechnology sector. His work not only contributes to scientific understanding but also holds the potential to revolutionize therapeutic approaches for various medical conditions. With ongoing collaborations and advancements, the future looks promising for Sandro and his contributions to the field.